Invited speakers and faculty for an activity presenting scientific or medical material should read the following statements and, by signature and date, indicate their willing agreement to uphold and follow these guidelines:
It is the CME Planning Committee’s policy to ensure balance, independence, objectivity and scientific rigor in all CME Activities. The desired outcome of this policy is to conduct a meeting that is free of the appearance of or actual ineligible company influence and the introduction and/or demonstration of bias in favor of or against a commercial product, service, or device in return for known or unknown personal and/or professional gain. Full and transparent disclosure will be the policy before and during the meeting.
All individuals in a position to influence the content must disclose all ineligible company financial relationships. Any speaker or planner who refuses to disclose will be disqualified from the planning, implementation and participation as a faculty or speaker in the Annual Meeting CME activity.
Speakers must disclose any limitations on presented information, such as data from ongoing research, interim analysis, preliminary data or unsupported opinion.
If unapproved (unlabeled) uses are discussed during the CME activity, the speaker must disclose that the product is not approved in the United States for the use under discussion.
Speakers must assure, either implicitly or explicitly, that clinical recommendations offered are valid in the care of patients. Scientific research reported, referred to or used in the presentation which is in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. All speakers will agree and ensure:
· Clinical care recommendations are based on evidence that is accepted within the profession of medicine as adequate justification for its use, indications and contraindications in patient care;
· Clinical care recommendation(s) must be justified by more than firmly held beliefs or hopes for efficacy;
· Data or information accepted in the medical profession support the recommendation(s);
· Conclusions drawn from the data must be those that are reasonably drawn from that data.